ANGIOCEPT Trademark

Trademark Overview

On Thursday, August 2, 2007, a trademark application was filed for ANGIOCEPT with the United States Patent and Trademark Office. The USPTO has given the ANGIOCEPT trademark a serial number of 77245120. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 26, 2011. This trademark is owned by Adnexus Therapeutics, Inc.. The ANGIOCEPT trademark is filed in the Pharmaceutical Products category with the following description:

Biotechnology and pharmaceutical products, namely, therapeutic proteins for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
angiocept

General Information

Serial Number77245120
Word MarkANGIOCEPT
Filing DateThursday, August 2, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 26, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 3, 2008

Trademark Statements

Goods and ServicesBiotechnology and pharmaceutical products, namely, therapeutic proteins for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 7, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameADNEXUS, A BRISTOL-MYERS SQUIBB R&D COMPANY
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWALTHAM, MA 02453
Party NameADNEXUS, A BRISTOL-MYERS SQUIBB R&D COMPANY
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressWALTHAM, MA 02453
Party NameAdnexus Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02453

Trademark Events

Event DateEvent Description
Monday, September 26, 2011ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 26, 2011ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 19, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 19, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 2, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, February 1, 2011EXTENSION 5 GRANTED
Friday, January 28, 2011EXTENSION 5 FILED
Friday, January 28, 2011TEAS EXTENSION RECEIVED
Wednesday, July 7, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, July 6, 2010EXTENSION 4 GRANTED
Thursday, July 1, 2010EXTENSION 4 FILED
Thursday, July 1, 2010TEAS EXTENSION RECEIVED
Monday, January 11, 2010EXTENSION 3 GRANTED
Thursday, January 7, 2010EXTENSION 3 FILED
Thursday, January 7, 2010TEAS EXTENSION RECEIVED
Thursday, December 17, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 17, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 10, 2009EXTENSION 2 GRANTED
Tuesday, July 14, 2009EXTENSION 2 FILED
Monday, August 10, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 14, 2009TEAS EXTENSION RECEIVED
Monday, January 19, 2009EXTENSION 1 GRANTED
Monday, January 19, 2009EXTENSION 1 FILED
Monday, January 19, 2009TEAS EXTENSION RECEIVED
Tuesday, August 26, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 3, 2008PUBLISHED FOR OPPOSITION
Wednesday, May 14, 2008NOTICE OF PUBLICATION
Tuesday, April 29, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 29, 2008ASSIGNED TO LIE
Tuesday, April 29, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 15, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 15, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 15, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 6, 2008AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, January 3, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 3, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 8, 2007NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 8, 2007NON-FINAL ACTION E-MAILED
Thursday, November 8, 2007NON-FINAL ACTION WRITTEN
Thursday, November 8, 2007ASSIGNED TO EXAMINER
Tuesday, August 7, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

angiocept diseases pharmaceutical disorders anti human namely solid organ immune auto